期刊文献+

体外研究黄酮类和芪类化合物对血脑屏障P-糖蛋白外排沙奎那韦的影响 被引量:5

Effects of several flavonoids and stilbenes on P-glycoprotein mediated efflux of saquinavir on blood-brain barrier in vitro
原文传递
导出
摘要 目的研究9种黄酮类化合物和5种芪类化合物对血脑屏障上P-糖蛋白(P-gp)外排沙奎那韦的影响。方法以过表达P-gp的马丁达比犬肾上皮细胞(MDCKII-MDR1)作为血脑屏障体外模型。药物干预分为16组(n=4),包括阴性对照组、阳性对照组、黄酮类实验I-IX组和芪类实验组Ⅰ-Ⅴ组。药物干预分别为50μmol·L^(-1)沙奎那韦(阴性对照组);50μmol·L^(-1)沙奎那韦联用50μmol·L^(-1)维拉帕米(阳性对照组);50μmol·L^(-1)沙奎那韦联用25μmol·L^(-1)黄酮类(黄酮类实验I-IX组)或联用25μmol·L^(-1)芪类化合物(芪类实验组Ⅰ-Ⅴ组)。药物干预时间均为4 h。用液相色谱质谱联用技术测定沙奎那韦在各组细胞内的积聚量。结果细胞内沙奎那韦积聚量:与阴性对照组(101.46±22.00)ng·mg^(-1)相比,柚皮素组(229.41±74.86)ng·mg^(-1)、桑黄素组(149.89±30.38)ng·mg^(-1)、白杨黄素组(209.75±65.35)ng·mg^(-1)、氧化白藜芦醇组(178.54±44.40)ng·mg^(-1)、染料木黄酮组(294.49±66.35)ng·mg^(-1)、表儿茶素组(212.27±49.70)ng·mg^(-1)、三乙酰白藜芦醇组(290.94±45.54)ng·mg^(-1)和白藜芦醇三甲醚组(205.55±35.16)ng·mg^(-1),均显著升高,差异有统计学意义(P<0.05);异槲皮苷组(61.98±11.02)ng·mg^(-1)、槲皮素组(41.54±4.92)ng·mg^(-1)和白藜芦醇组(29.59±4.61)ng·mg^(-1)细胞内沙奎那韦积聚量,均显著降低,差异有统计学意义(P<0.05)。结论一些黄酮类、芪类化合物可能对P-gp介导的沙奎那韦在血脑屏障上的转运过程产生调节作用。 Objective To investigate the effects of 9 flavonoids and 5 stilbenes on the P - glycoprotein ( P - gp) mediated efflux of saquinavir on blood - brain barrier (BBB) in vitro. Methods Madin - Darby ca- nine kidney cells (MDCKII -MDR1 ) expressing P-gp were performed as an in vitro blood - brain barrier ( BBB ) model. Incubations were divi- ded into 16 groups (n =4), including a negative control group, a posi- tive control group, 9 flavonoid intervention groups, and 5 stilbene inter- vention groups. In negative control group, cells were incubated in 50 μmol · L^-1 saquinavir. In positive control group, cells were incubated in 50 μmol · L^-l saquinavir in the presence of 50 μmol ·L^-1 verapamil. In flavonoid intervention groups ( I - IX ), cells were incubated in 50 μmol · L^-1 saquinavir in the presence of 25 μmol ·L^-lcertain flavonoid.In stilbene intervention groups ( I - V ), cells were incubated in 50 μmol · L^-1 saquinavir in the presence of 25 μmol · L^-1 certain stilbene. Incubations were terminated after 4 h. The intracellular concentrations of saquinavir were determined using a high - performance liquid chromatography - tandem mass spectrometry ( HPLC - MS/MS) method. Results Compared with the negative control group (101.46 ± 22. 00) ng · mg^-1, the accmnulation of saquinavir in MDCKII - MDRI cells in the presence of naringenin (229. 41± 74. 86 ) ng ·mg^-1, morinhydrate ( 149. 89 ± 30. 38 ) ng·mg^-1 chrysin (209.75 ± 65. 35) ng · rng^-1 , genistein ng.mg , , and oxyresveratrol (178.54 ± 44.40) ng ·mg^-1 (294.49±66.35) ng · mg^-1, L - epicatechin (212.27 ±49.70) ng · mg-^1, triacetyl - resveratrol (290.94 ±45.54) -1 1 ng· mg , and 3,4' ,5 - trimethoxy - trans - stilbene (205. 55 ±35. 16) ng · mg- increased significantly (P 〈 0. 05 ). In contrast, the accumulation of saquinavir in MDCKII -MDR1 cells in the presence ofisoquercitrin (61.98 ± 11.02 ) ng· mg^-1 , quercetin (41.54±4.92) ng · rng^-1 , and resveratrol (29.59 ±4.61) ng · mg^-1 decreased significantly (P〈0.05). Conclusion Several flavonoids and stilbenes may exert modulaory efiects on P-gp mediated efflux of saquinavir on BBB.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2016年第23期2187-2190,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学青年基金资助项目(81102877)
关键词 沙奎那韦 黄酮类 芪类 P-糖蛋白 液相色谱-质谱联用 saquinavir flavonoids stilbenes P - glycoprotein HPLC/MS - MS
  • 相关文献

参考文献2

二级参考文献16

  • 1David J. Brayden,Joanna Griffin. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers[J] 2008,Veterinary Research Communications(1):93~106
  • 2Fuxing Tang,Kazutoshi Horie,Ronald T. Borchardt. Are MDCK Cells Transfected with the Human MDR1 Gene a Good Model of the Human Intestinal Mucosa?[J] 2002,Pharmaceutical Research(6):765~772
  • 3Barbara Rothen-Rutishauser,Annette Braun,Maja Günthert,Heidi Wunderli-Allenspach. Formation of Multilayers in the Caco-2 Cell Culture Model: A Confocal Laser Scanning Microscopy Study[J] 2000,Pharmaceutical Research(4):460~465
  • 4Yuanchao Zhang,Leslie Z. Benet. Characterization of P-glycoprotein Mediated Transport of K02, a Novel Vinylsulfone Peptidomimetic Cysteine Protease Inhibitor, Across MDR1-MDCK and Caco-2 Cell Monolayers[J] 1998,Pharmaceutical Research(10):1520~1524
  • 5Moo J. Cho,David P. Thompson,Clay T. Cramer,Thomas J. Vidmar,Jeffrey F. Scieszka. The Madin Darby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier[J] 1989,Pharmaceutical Research(1):71~77
  • 6Abbott N J, Patabendige AAK, Dolman DEM, et al. Structure and function of the blood - brain barrier[ J]. Neurobiol Dis, 2010, 37 : 13 - 25.
  • 7Zlokovic BV. The blood - brain barrier in health and chronic neuro- degenerative disorders[J]. Neuron, 2008, 57:178-201.
  • 8Dominguez A, 61varez A, Hilario E, et al. Central nervous system diseases and the role of the blood - brain barrier in their treatment [ J]. Neurosci Discov, 2013, 1 : 3.
  • 9Miller DS. Regulation of P - glycopmtein and other ABC drug trans- porters at the blood - brain barrier [ J ]. Trends Pharmacol Sci, 2010, 31:246-254.
  • 10Robey RW, Masse), PR, Amiri - Kordestani L, et al. ABC trans- porters: unvalidated therapeutic targets in cancer and the CNS [ J ]. Anticancer Agents Med Chem, 2010, 10 : 625 - 633.

共引文献13

同被引文献25

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部